CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. (CNSP) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CNSP · as of Jun 9, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
CNS Pharmaceuticals, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CNSP insider buying and selling by quarter
CNSP insider selling · CNSP insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · CNSP ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CNSP executive sell shares · CNSP board member insider trading · CNSP insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 18, 2026 | Charles Faith L. Director | Purchase | 7,100 | $34K | Form 4 |
| Aug 22, 2023 | Downs Christopher CFO | Purchase | 27,000 | $34K | Form 4 |
| Aug 16, 2023 | Climaco John M CEO · Director | Purchase | 2,750 | $5K | Form 4 |
| Dec 6, 2022 | Priebe Waldemar 10 percent owner | Sale | 5,500 | $14K | Form 4 |
| Dec 7, 2022 | Priebe Waldemar 10 percent owner | Sale | 5,500 | $14K | Form 4 |
| Dec 8, 2022 | Priebe Waldemar 10 percent owner | Sale | 5,500 | $13K | Form 4 |
| Dec 9, 2022 | Priebe Waldemar 10 percent owner | Sale | 2,798 | $7K | Form 4 |
| Mar 10, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 13, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $7K | Form 4 |
| Mar 14, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $7K | Form 4 |
| Mar 15, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 16, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 17, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 20, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $5K | Form 4 |
| Mar 21, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $6K | Form 4 |
| Mar 22, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $5K | Form 4 |
| Mar 23, 2023 | Priebe Waldemar 10 percent owner | Sale | 10,000 | $11K | Form 4 |
| Mar 24, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $5K | Form 4 |
| Mar 27, 2023 | Priebe Waldemar 10 percent owner | Sale | 5,000 | $5K | Form 4 |
| Mar 28, 2023 | Priebe Waldemar 10 percent owner | Sale | 10,000 | $10K | Form 4 |
| Apr 28, 2023 | Climaco John M CEO · Director | Option | 1,250 | — | Form 4 |
| Apr 28, 2023 | Downs Christopher CFO | Option | 521 | — | Form 4 |
| Apr 19, 2023 | Gumulka Jerzy Director | Purchase | 2,500 | $4K | Form 4 |
| Apr 17, 2023 | Downs Christopher CFO | Purchase | 3,100 | $10K | Form 4 |
| Apr 10, 2023 | Gumulka Jerzy Director | Purchase | 7,173 | $5K | Form 4 |
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CNSP insider trading
CNSP insider trades
CNS Pharmaceuticals, Inc. (CNSP) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Charles Faith L. (Director). Over the past 12 months, 1 insiders have filed transactions with the SEC. CNSP insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For CNS Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CNSP insider trading · 5 questionsThe insiders of CNS Pharmaceuticals, Inc. (CNSP) include executives and directors such as Charles Faith L. (Director), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026